Science Pool

INDiGO: Fastest Route to the Clinic Fact Sheet

Learn more about INDiGO and Evotec’s integrated preclinical development capabilities to de-risk and accelerate IND-enabling programs:

  • Typically, drug candidates can be advanced from candidate selection to IND-submission in 48–52 weeks
  • Our experienced team not only executes R&D projects, but also proactively contributes to your scientific strategy
  • Clients can either opt for the full INDiGO platform or selected preclinical development and CMC components